Medeloop

About

Medeloop is an AI-powered clinical research platform that is redefining how medical evidence is generated and utilized across the healthcare industry. The company's mission is to empower clinical researchers and healthcare teams with AI tools to generate evidence more efficiently, thoroughly, and productively. Medeloop has built what it describes as an 'operating system for clinical research,' spanning the full research lifecycle from grant discovery and funding acquisition through real-world evidence generation from patient data to delivering actionable intelligence at the point of care. The platform offers a comprehensive suite of AI-powered products including Analytics for real-world evidence generation, EvidenceKit for accessing all-payer claims data, Grants for AI-assisted grant discovery and proposal writing, and Care for population health management and patient intelligence. Trusted by leading institutions including Stanford Medicine, Duke, Hartford Healthcare, Cedars-Sinai, NYU, and UC San Diego, Medeloop processes data from over 180 million real-world patient records. The company was founded in 2021, originated from Stanford University, and is headquartered in San Francisco, California, with offices in Montreal, Canada. Backed by world-class investors including General Catalyst, Inovia Capital, Maven Ventures, Icon Ventures, and Healthier Capital, Medeloop has raised $24 million in total funding to accelerate the future of health research.